pepmg_

Study summary · research use only

AMPK activator AICAR promotes 5-FU-induced apoptosis in gastric cancer cells

Study · human · Molecular and cellular biochemistry · 2016 · DOI 10.1007/s11010-015-2592-y · PMID 26497305

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

In this in vitro study (species not specified for the SGC-7901 gastric carcinoma cell line, though a human immortalized gastric epithelial line was used for comparison), the effect of the AMPK activator AICAR on apoptosis was examined, alone and combined with 5-fluorouracil (5-FU). Cells were treated with AICAR (0.2-5 mM) for 24-48 h. The abstract reports that AICAR reduced cellular viability and increased apoptosis in a time- and dose-dependent manner, associated with increased phosphorylated AMPK (p-AMPK), and enhanced the sensitivity of cells to 5-FU-induced reduction in viability and increased apoptosis. AICAR also increased expression of the tumor suppressor genes FBXW7, SEMA3F, and p21(Cip1) while reducing mdr1 expression; p-AMPK levels were reported as reduced in 5-FU-resistant cells compared with the other lines tested.

Abstract

The aim of the present study was to determine the effect of AICAR, an AMPK activator, on apoptosis in gastric carcinoma cells (SGC-7901) with or without 5-fluorouracil (5-FU). SGC-7901 cells were treated with AICAR (0.2-5 mM, for 24-48 h) with or without 5-FU. Cell viability was determined using MTT assay, while apoptosis were measured through the evaluation of active caspase-3 activity and DNA fragmentation. Real-time PCR was employed to determine the expression of tumor suppressor and multi-drug resistant (mdr1) gene. Cleaved caspase-3 and phosphorylated AMPK (p-AMPK) were measured by Western blot. AICAR significant reduced cellular viability but increased apoptosis in a time- and dose-dependent manner, which is associated with an increase in p-AMPK levels. Importantly, AICAR enhanced the sensitivity to 5-FU-induced reduction of cellular viability and increased apoptosis in SGC-7901 cells. Furthermore, AICAR increased tumor suppressor genes [F-box and WD repeat domain containing 7 (FBXW7), semaphorin III/F (SEMA3F), and p21(Cip1) (p21)] but reduced mdr1 expression. Finally, p-AMPK levels were reduced in 5-FU-resistant gastric cancer cells compared to human immortalized gastric epithelial cell line and 5-FU-sensitive gastric cancer cells. AICAR not only induces apoptosis alone but also enhances pro-apoptotic effect of 5-FU in SGC-7901 cells, which lays an experimental foundation to develop AICAR as a chemotherapeutic sensitizer against gastric cancer.

Read the full study on PubMed ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.